Skip to Main Content
Yale School of Medicine
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Yale School of Medicine
/
FIB-SEM Collaboration Core (F-SCC)
MENU
Yale School of Medicine
MENU
FIB-SEM Collaboration Core (F-SCC)
Collaborations
News
People
Publications
Discoveries
YSM Home
INFORMATION FOR
About YSM
Faculty
Staff
Students
Residents & Fellows
Patients
Researchers
Alumni
Popular Links
Search
17 results
Refine
People (19223)
Web Pages (12542)
Documents (6941)
News (52969)
Events (27549)
Media (2878)
Clinical Trials (641)
Gender
Male (0)
Female (0)
Accept Healthy Volunteers
Yes (0)
No (0)
Categories
Addictive Behavior (0)
Aging (0)
Alcohol Addiction (0)
Alzheimer's (0)
Arthritis (0)
Asthma (0)
Autism (0)
Blood Disorders (0)
Brain & Spinal Cord & Nervous System (0)
Cancer (17)
Bladder (0)
Brain (0)
Breast (0)
Colorectal (0)
Gynecological (0)
Head and Neck (0)
Kidney (0)
Leukemia (0)
Liver (0)
Lung (0)
Lymphoma (0)
Melanoma (0)
Myeloma (0)
Non-Therapeutic (0)
Other Cancers (0)
Pancreas (0)
Pediatric Cancers (0)
Phase 1 (17)
Prevention (0)
Prostate (0)
Sarcoma (0)
Stomach and Esophagus (0)
Supportive Care (0)
Thyroid (0)
Children Health (0)
COVID-19 (0)
Diabetes (0)
Digestive System (0)
Diseases of the Respiratory Systems (0)
Endocrine System (0)
Genetics (0)
Headaches (0)
Hearing/Ear (0)
Heart/Cardiovascular (0)
Hepatitis (0)
HIV/AIDS (0)
Immune System (0)
Infants & Newborns (0)
Infectious Disease (0)
Kidney & Urinary Tract (0)
Liver (0)
Lung (0)
Men Health (0)
Mental Health & Behavioral Research (0)
Muscle & Bone (0)
Obesity & Weight Management (0)
Pain Control (0)
Poisoning/Injury (0)
Pregnancy and Obstetrics (0)
Sickle Cell (0)
Skin/Dermatology (0)
Sleep Disorders (0)
Tobacco Addiction (0)
Vision/Eye (0)
Women Health (0)
Status
New (0)
IRB Initial Approval (0)
PRC Approval (0)
Project Manager Signoff (0)
Open to Accrual (17)
Closed to Accrual (0)
For Affiliates Only (0)
IRB Study Closure (0)
Age
Select a year
Select a year
Less than 1 year
1 year
2 years
3 years
4 years
5 years
6 years
7 years
8 years
9 years
10 years
11 years
12 years
13 years
14 years
15 years
16 years
17 years
18 years
19 years
20 years
21 years
22 years
23 years
24 years
25 years
26 years
27 years
28 years
29 years
30 years
31 years
32 years
33 years
34 years
35 years
36 years
37 years
38 years
39 years
40 years
41 years
42 years
43 years
44 years
45 years
46 years
47 years
48 years
49 years
50 years
51 years
52 years
53 years
54 years
55 years
56 years
57 years
58 years
59 years
60 years
61 years
62 years
63 years
64 years
65 years
66 years
67 years
68 years
69 years
70 years
71 years
72 years
73 years
74 years
75 years
76 years
77 years
78 years
79 years
80 years
81 years
82 years
83 years
84 years
85 years
86 years
87 years
88 years
89 years
90 years
Search
Profile
Patricia LoRusso
Clear
Search
Showing 17 results
in 'Clinical Trials'
Clinical Trials
Phase 1
Patricia LoRusso
Clinical Trial
A Phase 1 Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, and Anti-tumor Activity of PF-07248144 in Participants With Advanced or Metastatic Solid Tumors
Clinical Trial
A Phase 1 Study of ASP3082 in Participants With Previously Treated Locally Advanced or Metastatic Solid Tumor Malignancies With KRAS G12D Mutation
Clinical Trial
A Phase 1 Study of HMBD-002-V4C26 (HMBD-002), a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid Malignancies
Clinical Trial
A Phase 1 Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of GS-1811, an Afucosylated Anti-CCR8 Monoclonal Antibody, as Monotherapy and in Combination With an Anti-PD-1 Monoclonal Antibody in Adults With Advanced Solid Tumors
Clinical Trial
A Phase 1, Multi-center, Open Label First-in-Human Study With ABBV-CLS-579 Alone and in Combination With Anti-PD-1 in Subjects With Locally Advanced or Metastatic Tumors
Clinical Trial
A Phase 1/1b Dose Escalation/Expansion Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
Clinical Trial
A Phase 1/2 Multiple Expansion Cohort Trial of MRTX849 in Patients With Advanced Solid Tumors With KRAS G12C Mutation KRYSTAL-1
Clinical Trial
A Phase 1/2 Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE)
Clinical Trial
A Phase 1/2, Dose Escalation and Expansion Study of the Safety, Tolerability, and Anti-tumor Activity of BND-22 Administered Alone and in Combination With Pembrolizumab or With Cetuximab in Patients With Advanced Solid Tumors
Clinical Trial
A Phase 1a/1b Study of LY3537982 in Patients With KRAS G12C-Mutant Advanced Solid Tumors
Clinical Trial
A Phase I Dose-Escalation and Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation
Clinical Trial
A Phase I, Open Label, Multicenter, Dose-escalation Study of BI 907828 in Adult Patients With Wild-type TP53 Enriched Advanced Solid Tumors and Expansion in Patients With MDM2 Amplified Advanced Solid Tumors
Clinical Trial
An Open-label, Dose Escalation, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid Tumors
Clinical Trial
Open Label, Multicenter, Phase 1 Study to Evaluate the Maximum Tolerated Dose of Orally Administered CB-03-10 With Dose Expansion Phase, in Subjects With Advanced Solid Tumors
Clinical Trial
Phase 1 Study of the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of RP-6306 in Patients With Advanced Solid Tumors (MYTHIC Study)
Clinical Trial
Phase I, First-in-human, Open-label, Dose Escalation Trial to Evaluate Safety, Pharmacokinetics, Pharmacodynamics, and Anti-tumor Activity of BNT152+153 in Patients With Solid Tumors
Clinical Trial
Phase Ib/II Study of ZEN003694 and Entinostat in Advanced and Refractory Solid Tumors and Lymphomas
Your browser is antiquated and no longer supported on this website. Please update your browser or switch to Chrome, Firefox or Safari.
You can update your IE here:
https://support.microsoft.com/en-us/help/17621/internet-explorer-downloads
[7640,9243,2243,2317,8261,8480,8766,2324,3053]
{"namedChunks":["modules-page-components-ComponentWrapper","modules-search-components-global-search-GlobalSearchContainer","modules-footer-components-Footer"]}